SIREN : 823905898
KERNEL BIOMEDICAL is a French company founded 9 years ago, specialized in the sector Ingénierie, études techniques. Based in ROUEN (76000), this company of category PME has financial data available below. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2018 |
|---|---|
| Revenue | N/C |
| Net income | 0 € |
| EBITDA | N/C |
| Net margin | N/C |
In 2018, KERNEL BIOMEDICAL records a net loss of 0 €. This deficit will reduce equity on the balance sheet.
The liquidity ratio (= Current assets / Current liabilities) stands at 331.71. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
331.708
In 2018, the liquidity ratio of KERNEL BIOMEDICAL (331.71) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Compare KERNEL BIOMEDICAL with other companies in the same sector:
Voir toutes les statistiques du secteur Ingénierie, études techniques
The revenue of KERNEL BIOMEDICAL is not publicly disclosed (confidential accounts filed with INPI).
Profitability information is not publicly available.
The headquarters of KERNEL BIOMEDICAL is located in ROUEN (76000), in the department Seine-Maritime.
The tax return of KERNEL BIOMEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
KERNEL BIOMEDICAL operates in the sector Ingénierie, études techniques (NAF code 71.12B). See the 'Sector positioning' section above to compare the company with its competitors.